Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | N/A | 2 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $2 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $N/A | $N/A | $N/A | $N/A | $7 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 150 |
| Other current liabilities | N/A | N/A | N/A | N/A | 910 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,070 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $N/A | $N/A | $N/A | $1,070 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,379 | N/A | N/A | N/A | N/A |
| Common Shares | N/A | N/A | N/A | N/A | 440 |
| Retained earnings | N/A | N/A | N/A | N/A | -4,170 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 10 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $-1,060 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $10 |